American Century Companies Inc Harmony Biosciences Holdings, Inc. Transaction History

American Century Companies Inc

$157 Billion
Q1 2025

A detailed history of American Century Companies Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,288,787 shares of HRMY stock, worth $44.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,288,787

Previous 1,102,604 16.89%

Holding current value

$44.5 Million

Previous $37.9 Million 12.74%

% of portfolio

0.03%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$32.18 - $40.46 $5.99 Million - $7.53 Million	186,183 Added 16.89%	1,288,787 $42.8 Million
Q4 2024 Feb 11, 2025	BUY	$31.86 - $41.49 $7.84 Million - $10.2 Million	246,140 Added 28.74%	1,102,604 $37.9 Million
Q3 2024 Nov 12, 2024	BUY	$30.0 - $39.95 $5.25 Million - $6.99 Million	174,928 Added 25.67%	856,464 $34.2 Million
Q2 2024 Aug 07, 2024	BUY	$28.81 - $33.01 $6.86 Million - $7.86 Million	238,140 Added 53.71%	681,536 $20.6 Million
Q1 2024 May 14, 2024	BUY	$29.93 - $35.06 $7.09 Million - $8.31 Million	236,977 Added 114.8%	443,396 $14.9 Million
Q4 2023 Feb 13, 2024	BUY	$19.2 - $33.78 $3.96 Million - $6.97 Million	206,419 New	206,419 $6.67 Million
Q3 2023 Nov 13, 2023	SELL	$31.89 - $39.03 $8.53 Million - $10.4 Million	-267,431 Reduced 56.53%	205,609 $6.74 Million
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $4.32 Million - $5.3 Million	-141,801 Reduced 23.06%	473,040 $16.6 Million
Q1 2023 May 11, 2023	SELL	$30.8 - $53.92 $1.18 Million - $2.07 Million	-38,441 Reduced 5.88%	614,841 $20.1 Million
Q4 2022 Feb 13, 2023	SELL	$45.4 - $60.91 $2.75 Million - $3.69 Million	-60,583 Reduced 8.49%	653,282 $36 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $2.44 Million - $3.21 Million	57,919 Added 8.83%	713,865 $31.6 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $3.01 Million - $4.67 Million	89,638 Added 15.83%	655,946 $32 Million
Q1 2022 May 11, 2022	BUY	$33.14 - $51.13 $3 Million - $4.63 Million	90,484 Added 19.02%	566,308 $27.6 Million
Q4 2021 Feb 07, 2022	BUY	$34.09 - $43.91 $9.78 Million - $12.6 Million	287,013 Added 152.01%	475,824 $20.3 Million
Q3 2021 Nov 10, 2021	BUY	$25.68 - $38.61 $1,797 - $2,702	70 Added 0.04%	188,811 $7.24 Million
Q2 2021 Aug 05, 2021	BUY	$25.96 - $33.44 $977,394 - $1.26 Million	37,650 Added 24.92%	188,741 $5.33 Million
Q1 2021 May 14, 2021	BUY	$27.56 - $40.37 $896,857 - $1.31 Million	32,542 Added 27.45%	151,091 $4.99 Million
Q4 2020 Feb 12, 2021	BUY	$31.74 - $51.34 $550,276 - $890,081	17,337 Added 17.13%	118,549 $4.29 Million
Q3 2020 Nov 13, 2020	BUY	$30.96 - $44.39 $3.13 Million - $4.49 Million	101,212 New	101,212 $3.43 Million

Others Institutions Holding HRMY

# of Institutions

278

Shares Held

44.9M

Call Options Held

130K

Put Options Held

46.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Harmony Biosciences Holdings, Inc. Transaction History